The legal inquiries center on whether the proposed transaction terms unfairly limit superior competing offers or provide benefits to insiders that are not extended to the broader shareholder base. For Element Solutions, the deal involves a cash-and-stock acquisition by Solstice Advanced Materials, while InMed Pharmaceuticals faces scrutiny over its merger with Mentari Therapeutics. Similarly, the firm is examining the stock-for-stock merger between Huntsman Corporation and Olin Corporation.

Halper Sadeh LLC indicates that it may pursue litigation to secure increased compensation or additional financial disclosures for affected investors. The firm operates on a contingent fee basis for these matters, asserting that its past interventions have led to corporate reforms and significant recoveries for investors globally. Shareholders holding positions in these companies are being encouraged to review their rights regarding the potential impact of these corporate consolidations.